Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Mar 26, 2022 6:45pm
174 Views
Post# 34548830

RE:RE:Let’s try to be positive

RE:RE:Let’s try to be positiveI heard that too from someone who attributed it to the CFO. I don't doubt he may have said something like that but it is unlikely that he viewed what he was saying as anything other than a possibility, which it is. I don't think he would be predicting that as a certainty. So, it is nice to hear such a sentiment but I don't think you invest based on that.
palinc2000 wrote: Who told you that they are confident that the Convert will be converted? That would be great but I have never seen or heard that from the Company

Biobob wrote: For what it's worth they still think the convertible will be converted in 12 months.. 14.85$... th1902 is the only possible way to get there.  It's a love hate company, maybe they make 2018 comeback.  Obviously what else can the tell investors but being the most patient and faithful investors of the history of markets we can still hope.




<< Previous
Bullboard Posts
Next >>